AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom.
$16.59+5.80%
报价 2026-11-06
市值
$412.1M
EV
$428.1M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -0.7%
$3.27$16.71
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Devices| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RCELAVITA Medical, Inc. | $412.1M | +5.8% | – | 81.6% | – | – | – | |
| DCTHDelcath Systems, Inc. | $518.1M | +3.0% | +22.1% | 87.1% | 1515.5x | 312.9x | 32.9x | GARP |
| SENSSenseonics Holdings, Inc. | $454.2M | +7.5% | +77.0% | 54.9% | – | – | – | 高增长 |
| BWAYBrainsWay Ltd. | $437.3M | +5.1% | – | 75.4% | 62.4x | 74.0x | – | |
| MASS908 Devices Inc. | $436.5M | +4.0% | +25.6% | 49.8% | – | – | 911.9x | |
| NPCENeuroPace, Inc. | $429.1M | -1.5% | +4.8% | 77.2% | – | – | – | |
| SSIISS Innovations International, Inc. | $423M | +11.1% | – | 47% | – | – | – | |
| CERSCerus Corporation | $407.9M | -5.2% | +9.4% | 52.1% | – | 226.7x | – | |
| VMDViemed Healthcare, Inc. | $347.7M | +1.3% | +16.7% | 57% | 23.4x | 6.9x | 28.7x | GARP |
| 同行中位数 | – | – | +19.4% | 55.9% | 62.4x | 150.3x | 32.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。